{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:37:09Z","timestamp":1761129429938},"reference-count":22,"publisher":"Editorial Committee of Japanese Journal of Infectious Diseases, National Institute of Infectious Dis","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn J Infect Dis"],"published-print":{"date-parts":[[2017]]},"DOI":"10.7883\/yoken.jjid.2016.480","type":"journal-article","created":{"date-parts":[[2017,3,27]],"date-time":"2017-03-27T18:08:59Z","timestamp":1490638139000},"page":"502-506","source":"Crossref","is-referenced-by-count":5,"title":["QuantiFERON-TB Gold In-Tube Test for Tuberculosis Prevention in HIV-Infected Patients"],"prefix":"10.7883","volume":"70","author":[{"given":"Thana","family":"Khawcharoenporn","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Faculty of Medicine, Thammasat University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjawan","family":"Phetsuksiri","sequence":"additional","affiliation":[{"name":"National Institute of Health, Department of Medical Sciences, Ministry of Public Health"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janisara","family":"Rudeeaneksin","sequence":"additional","affiliation":[{"name":"National Institute of Health, Department of Medical Sciences, Ministry of Public Health"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sopa","family":"Srisungngam","sequence":"additional","affiliation":[{"name":"National Institute of Health, Department of Medical Sciences, Ministry of Public Health"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anucha","family":"Apisarnthanarak","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Faculty of Medicine, Thammasat University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4631","reference":[{"key":"1","unstructured":"1. World Health Organization (WHO). Guidelines for intensified tuberculosis case-finding and preventive therapy for people living with HIV in resource-constrained settings. 2011. Geneva, Switzerland. Available at &lt;http:\/\/apps.who.int\/iris\/bitstream\/10665\/44472\/1\/9789241500708_eng.pdf&gt;. Accessed June 1, 2016."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Cattamanchi A, Smith R, Steingart KR, et al. Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis. J Acquir Immune Defic Syndr. 2011;56:230-8.","DOI":"10.1097\/QAI.0b013e31820b07ab"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Akolo C, Adetifa I, Shepperd S, et al. Treatment of latent tuberculosis infection in HIV infected persons. Cochrane Database Syst Rev. 2010;1:CD000171.","DOI":"10.1002\/14651858.CD000171.pub3"},{"key":"4","unstructured":"4. Mazurek GH, Jereb J, Vernon A, et al. Centers for Disease Control and Prevention. Updated guidelines for using interferon gamma release assays to detect <i>Mycobacterium tuberculosis<\/i> infection\u2013United States, 2010. MMWR Recomm Rep. 2010;59:1-25."},{"key":"5","unstructured":"5. Khawcharoenporn T, Apisarnthanarak A, Sungkanuparph S, et al. Tuberculin skin test and isoniazid prophylaxis among health care workers in high tuberculosis prevalence areas. Int J Tuberc Lung Dis. 2011;15:14-23."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Diel R, Goletti D, Ferrara G, et al. Interferon-\u03b3 release assays for the diagnosis of latent <i>Mycobacterium tuberculosis<\/i> infection: a systematic review and meta-analysis. Eur Respir J. 2011;37:88-99.","DOI":"10.1183\/09031936.00115110"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Gray J, Reves R, Johnson S, et al. Identification of false-positive QuantiFERON-TB Gold In-Tube assays by repeat testing in HIV-infected patients at low risk for tuberculosis. Clin Infect Dis. 2012;54:e20-3.","DOI":"10.1093\/cid\/cir792"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Aichelburg MC, Reiberger T, Breitenecker F, et al. Reversion and conversion of interferon-\u03b3 release assay results in HIV-1-infected individuals. J Infect Dis. 2014;209:729-33.","DOI":"10.1093\/infdis\/jit418"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Carrara S, Vincenti D, Petrosillo N, et al. Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy. Clin Infect Dis. 2004;38:754-6.","DOI":"10.1086\/381754"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Ribeiro S, Dooley K, Hackman J, et al. T-SPOT.TB responses during treatment of pulmonary tuberculosis. BMC Infect Dis. 2009;9:23.","DOI":"10.1186\/1471-2334-9-23"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Chee CB, KhinMar KW, Gan SH, et al. Latent tuberculosis infection treatment and T-cell responses to <i>Mycobacterium tuberculosis<\/i>-specific antigens. Am J Respir Crit Care Med. 2007;175:282-7.","DOI":"10.1164\/rccm.200608-1109OC"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Chiappini E , Bonsignori F , Mangone G, et al. Serial T-SPOT.TB and QuantiFERON TB-Gold In-Tube assays to monitor response to antitubercular treatment in Italian children with active or latent tuberculosis infection. Pediatr Infect Dis J. 2012;31:974-7.","DOI":"10.1097\/INF.0b013e31825d0d67"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Lee SW, Lee SH, Yim JJ. Serial interferon-gamma release assays after chemoprophylaxis in a tuberculosis outbreak cohort. Infection. 2012;40:431-5.","DOI":"10.1007\/s15010-012-0265-2"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Johnson JL, Geldenhuys H, Thiel BA, et al. Effect of isoniazid therapy for latent TB infection on QuantiFERON-TB Gold In-Tube responses in adults with positive tuberculin skin test results in a high TB incidence area: a controlled study. Chest. 2014;145:612-7.","DOI":"10.1378\/chest.13-1232"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Pullar ND, Steinum H, Bruun JN, et al. HIV patients with latent tuberculosis living in a low-endemic country do not develop active disease during a 2 year follow-up; a Norwegian prospective multicenter study. BMC Infect Dis. 2014;14:667.","DOI":"10.1186\/s12879-014-0667-0"},{"key":"16","unstructured":"16. WHO. Tuberculosis country profiles, 2014. Available at &lt;http:\/\/www.who.int\/tb\/country\/data\/profiles\/en\/&gt;. Accessed August 13, 2016."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Apisarnthanarak A, Mundy LM. Application of a 3-item adherence metric to monitor antiretroviral medication adherence in a resource-limited setting. J Acquir Immune Defic Syndr. 2010;55:528.","DOI":"10.1097\/QAI.0b013e3181eec0c4"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Aberg JA, Gallant JE, Ghanem KG, et al. Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2014;58:1-10.","DOI":"10.1093\/cid\/cit757"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Lee SW, Lee SH, Yim JJ. Serial interferon-gamma release assays after chemoprophylaxis in a tuberculosis outbreak cohort. Infection. 2012;40:431-5.","DOI":"10.1007\/s15010-012-0265-2"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Higuchi K, Harada N, Mori T. Interferon-gamma responses after isoniazid chemotherapy for latent tuberculosis. Respirology. 2008;13:468-72.","DOI":"10.1111\/j.1440-1843.2008.01244.x"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Bastos ML, Menzies D, Belo MT, et al. Changes in QuantiFERON-TB Gold In-Tube results during treatment for tuberculous infection. Int J Tuberc Lung Dis. 2013;17:909-16.","DOI":"10.5588\/ijtld.12.0927"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Vilaplana C, Ruiz-Manzano J, Gil O, et al. The tuberculin skin test increases the responses measured by T cell interferon-gamma release assays. Scand J Immunol. 2008;67:610-7.","DOI":"10.1111\/j.1365-3083.2008.02103.x"}],"container-title":["Japanese Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/70\/5\/70_JJID.2016.480\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T03:06:18Z","timestamp":1568948778000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/yoken\/70\/5\/70_JJID.2016.480\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.7883\/yoken.jjid.2016.480","relation":{},"ISSN":["1344-6304","1884-2836"],"issn-type":[{"value":"1344-6304","type":"print"},{"value":"1884-2836","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}